GSK249320 is a monoclonal antibody directed against myelin associated glycoprotein (MAG), a
protein that inhibits axonal regeneration. GSK249320 acts as a MAG antagonist, and through
this activity it is hypothesised that it will enhance recovery from neuronal degeneration
following acute axonal injury, which occurs in spinal cord injury or stroke.